Skin Lesion Evaluation Simplified.

A handheld device that will assist you in checking skin lesions for cancer in seconds.

Sign Up Now

DermaSensor Features

The Future Standard of Skin Care

  • Used in ~20 seconds per skin lesion
  • Will provide an instant "High Risk" or "Low Risk" result using DermaSensor's proprietary algorithm
  • Completely wireless, ergonomically designed and easy to hold
  • Always On / Always Ready, for whenever you need it

Simple Design, Simple to Use

  • Intuitive on-screen interface will guide you step-by-step through the evaluation
  • Will work at any angle by using the gentle-squeeze side buttons or hand-held touch-screen
DermaSensor is NOT a camera or a dermatoscope.

DermaSensor uses pulses of light and spectroscopy to assess lesions cellular and sub-cellular structure.

Non-Invasive Micron-Level Precision

  • Light emitting tip will gently and painlessly touch the surface of the skin while evaluating data below the skin surface
  • Precision optics within the tip will capture pathological irregularities throughout a skin lesion as small as 2mm

Always At Your Side

  • The handheld unit will charge wirelessly in the desktop base
  • Secure wireless connectivity will allow you to expand the use of the device into other applications
  • The DermaSensor device and base's efficient footprint will fit on any desk

Overview of How DermaSensor Will Work

1. Lesion Identification

Identify the lesion of concern on your patient

2. DermaSensor Scan

Gently touch the small device tip to the lesion, taking instant recordings at different positions of the lesion

3. Photon Scattering

Light scatters from particles in the cells of the skin tissue back to DermaSensor's spectral sensor

4. Algorithmic Analysis

The proprietary DermaSensor algorithm will analyze the reflected photons and provides an immediate "High Risk" or "Low Risk" result

Join our investor newsletter Sign Up Now

How the Technology Will Work

  • The tip of the DermaSensor will reflect and record quick bursts of light off the lesion’s cellular structures.
  • The light will be analyzed by the built-in computer to distinguish different types of malignant skin lesions (including melanomas, squamous cell carcinomas, and basal cell carcinomas) from benign skin lesions.
  • By examining the difference in light scattering, DermaSensor will determine if the skin lesion is “High Risk” vs “Low Risk,” an instantaneous and actionable output.
About ESS

DermaSensor uses Elastic Scattering Spectroscopy (ESS), a process which evaluates how photons scatter when reflected off different cellular structures. Malignant lesions have different cellular and sub-cellular structures than benign lesions, scattering light differently.

Who DermaSensor Will Be For


While Americans have much better access to Primary Care Physicians (PCPs), early diagnosis in primary care is hampered by limited consultation time and limited dermatology training. You will be able to use DermaSensor to better assess skin lesions and determine whether patients need additional clinical care.


Patients wait 32.3 days, on average, for an appointment with a Dermatologist. The total treatment costs for melanoma in situ is ~$4,648 while Stage IV melanoma is ~$159,808. DermaSensor will allow dermatologists and their care team to quickly and effectively evaluate lesions for cancer. Detecting cancer at an earlier stage can save lives and save the system and the patient money.

Retail Clinics

Retail clinic use has doubled in the last 5 years. Patients turn to retail clinics due to convenience, transparency of cost, and efficient service. Our device will allow patients to visit retail clinics with their skin lesion concerns and allow retail clinicians to efficiently evaluate lesions.

What is an Adjunctive Tool?

You will have a tool to allow you to look beyond the skin surface, giving you confidence in your decision-making. This quick tool will take ~20 seconds to use and will provide an actionable output to help inform next steps (e.g. referral or biopsy), saving you time and allowing you to spend more quality time with your patients.

DermaSensor is NOT a camera or a dermatoscope.

DermaSensor uses pulses of light and spectroscopy to assess lesions cellular and sub-cellular structure.


This device is not meant to replace clinicians, it is an adjunctive tool to provide clinicians with additional information about a suspicious lesion.

Patients will view this as supplemental to the care they receive from clinicians.

The non-invasive feature of the device will be non-confronting to the patient and provides them peace of mind.

The machine-learning algorithm will be derived from thousands of samples of pathologically verified lesions and is professionally trained by expert data scientists.

Opportunity to reduce the number of lesions unnecessary biopsied and referred.

Tech Specs


Unit and Base

  • Height: 234mm
  • Width: 105mm
  • Depth: 105mm

Handheld Unit

  • Height: 180mm
  • Width: 70mm
  • Depth: 37mm


  • Height: 124mm
  • Width: 105mm
  • Depth: 105mm

Dark Grey


Require WIFI internet connection

Battery Life

Battery will last a full day in practice *

* by keeping the device in the charging base between uses


Standard USB cable and USB power supply


3 year warranty with service contract *

* see Terms and Conditions for details

What's in the Box
  • Device (both handheld unit and base) pre-installed with software
  • Operating Manual
  • Recycable packaging
  • USB cable and USB wall adapter

Wireless charging

Why You Should Care About Skin Cancer in Your Practice

1 in 5 Americans are diagnosed with skin cancer in their lifetime. 1

Annual cost of treating skin cancers in the U.S. is estimated at $8.1 billion, with an estimated 5.4 million new cases of skin cancer each year. 2 3

Only 1 in 29.4 melanocytic lesions biopsied by PCPs is melanoma. 4

Primary Care Providers correctly diagnose melanoma only 42% of the time. 5

As Seen On